Skip to main content
Clinical Trials/NCT03660618
NCT03660618
Terminated
Not Applicable

LSFG-SKIN, Laser Speckle Flowgraphy

Randy Kardon1 site in 1 country1 target enrollmentMay 23, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Randy Kardon
Enrollment
1
Locations
1
Primary Endpoint
Imaging Blood Flow
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.

Detailed Description

Laser speckle skin blood flow (LSFG-SKIN) will be recorded in normal subjects and in patients with disorders affecting skin capillary perfusion, which may include cardiovascular disorders, dermatologic disorders, skin wounds, ocular disorders, psychiatric disorders, and neurologic disorders.

Registry
clinicaltrials.gov
Start Date
May 23, 2017
End Date
March 2, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Randy Kardon
Responsible Party
Sponsor Investigator
Principal Investigator

Randy Kardon

Randy Kardon M.D. Ph.D Professor and Director of Neuro-ophthalmology

University of Iowa

Eligibility Criteria

Inclusion Criteria

  • ●Healthy normal control subjects ages 18-90
  • Cardiology Subjects
  • Ages 18-90
  • History of dysrhythmia, heart failure, cardiac ischemia, hypertension, peripheral vascular disease
  • Dermatology Subjects
  • Ages 18-90
  • History of inflammatory and cancerous lesions
  • Endocrine Subjects
  • Ages 18-90
  • History of diabetes, thyroid disease

Exclusion Criteria

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma
  • Cardiology Subjects
  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma
  • Dermatology Subjects
  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma
  • Endocrine Subjects
  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.

Outcomes

Primary Outcomes

Imaging Blood Flow

Time Frame: One visit

Imaging blood flow in the tissue is of major importance in the clinical environment

Study Sites (1)

Loading locations...

Similar Trials